个性化文献订阅>期刊> FEBS Letters
 

Glucocorticoid suppresses BDNF-stimulated MAPK/ERK pathway via inhibiting interaction of Shp2 with TrkB

  作者 Kumamaru, E; Numakawa, T; Adachi, N; Kunugi, H  
  选自 期刊  FEBS Letters;  卷期  2011年585-20;  页码  3224-3228  
  关联知识点  
 

[摘要]Increased glucocorticoids (GCs) have been implicated in the pathophysiology of depressive disorder. We previously found that dexamethasone (DEX, a synthetic GC) repressed brain-derived neurotrophic factor (BDNF)-induced synaptic proteins via suppressing extracellular signal-regulated protein kinase (ERK) signaling. Here, we investigated the possible involvement of Src homology-2 domain-containing phosphatase2 (Shp2), an ERK signaling mediator. We found that DEX suppressed Shp2 interaction with TrkB, a receptor for BDNF, in cultured cortical neurons. NSC87877, a Shp2 inhibitor, mimicked DEX, and Shp2 overexpression reversed the effect of DEX, suggesting that GCs suppress ERK signaling through inhibiting the interaction of Shp2 with TrkB. Structured summary of protein interactions: TrkB physically interacts with Shp2 by anti bait coimmunoprecipitation (View interaction) FRS2 physically interacts with Shp2 by anti bait coimmunoprecipitation (View interaction) Grb2 physically interacts with Shp2 by anti bait coimmunoprecipitation (View interaction) (C) 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内